{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:12:56Z","timestamp":1785103976389,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05599-0","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T10:01:43Z","timestamp":1715335303000},"page":"1337-1343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interleukin levels and depressive symptoms in psoriatic arthritis patients: insights from a case\u2013control study on socio-demographic factors and disease perception"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-3997","authenticated-orcid":false,"given":"Marzena","family":"Waszczak-Jeka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5605-7554","authenticated-orcid":false,"given":"Pawe\u0142","family":"\u017buchowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0210-0318","authenticated-orcid":false,"given":"Marta","family":"Dura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0948-8129","authenticated-orcid":false,"given":"Agnieszka","family":"Bielewicz-Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-849X","authenticated-orcid":false,"given":"Micha\u0142","family":"Ku\u0142akowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5944-0150","authenticated-orcid":false,"given":"Alicja","family":"G\u00f3ralczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"issue":"14","key":"5599_CR1","doi-asserted-by":"publisher","first-page":"11662","DOI":"10.3390\/ijms241411662","volume":"24","author":"BW Lee","year":"2023","unstructured":"Lee BW, Moon SJ (2023) Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment. Int J Mol Sci 24(14):11662. https:\/\/doi.org\/10.3390\/ijms241411662","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5599_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00296-023-05393-4","volume":"43","author":"P \u017buchowski","year":"2023","unstructured":"\u017buchowski P, Dura M, Ka\u017amierczak K et al (2023) Comparison of advanced glycation end products concentration in the skin among patients with rheumatic diseases, with and without comorbid depression: a case-control study. Rheumatol Int 43(10):1829\u20131834. https:\/\/doi.org\/10.1007\/s00296-023-05393-4","journal-title":"Rheumatol Int"},{"issue":"2","key":"5599_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","volume":"41","author":"S Gupta","year":"2021","unstructured":"Gupta S, Syrimi Z, Hughes DM et al (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275\u2013284. https:\/\/doi.org\/10.1007\/s00296-020-04775-2","journal-title":"Rheumatol Int"},{"issue":"2","key":"5599_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clinthera.2023.01.006","volume":"45","author":"A Panagiotopoulos","year":"2023","unstructured":"Panagiotopoulos A, Fragoulis GE (2023) Comorbidities in psoriatic arthritis: a narrative review. Clin Ther 45(2):177\u2013189. https:\/\/doi.org\/10.1016\/j.clinthera.2023.01.006","journal-title":"Clin Ther"},{"issue":"2","key":"5599_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40744-020-00207-","volume":"7","author":"AJ Mathew","year":"2020","unstructured":"Mathew AJ, Chandran V (2020) Depression in psoriatic arthritis: dimensional aspects and link with systemic inflammation. Rheumatol Ther 7(2):287\u2013300. https:\/\/doi.org\/10.1007\/s40744-020-00207-","journal-title":"Rheumatol Ther"},{"issue":"9","key":"5599_CR6","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/acr","volume":"74","author":"A Wong","year":"2022","unstructured":"Wong A, Ye JY, Cook RJ et al (2022) Depression and anxiety reduce the probability of achieving a state of sustained minimal disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hobok) 74(9):1430\u20131434. https:\/\/doi.org\/10.1002\/acr","journal-title":"Arthritis Care Res (Hobok)"},{"issue":"6","key":"5599_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.semarthrit.2020.02.001","volume":"50","author":"EZ Zusman","year":"2020","unstructured":"Zusman EZ, Howren AM, Park JYE et al (2020) Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(6):1481\u20131488. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.02.001","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"5599_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s10067-020-05417-5","volume":"40","author":"E De Lorenzis","year":"2021","unstructured":"De Lorenzis E, Natalello G, Bruno D et al (2021) Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role? Clin Rheumatol 40(5):1893\u20131902. https:\/\/doi.org\/10.1007\/s10067-020-05417-5","journal-title":"Clin Rheumatol"},{"issue":"3","key":"5599_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol 55(3):379\u2013390. https:\/\/doi.org\/10.1007\/s12016-018-8702-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"5599_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5152\/eurjrheum.2017.17037","volume":"4","author":"EA Wang","year":"2017","unstructured":"Wang EA, Suzuki E, Maverakis E et al (2017) Targeting IL-17 in psoriatic arthritis. Eur J Rheumatol 4(4):272\u2013277. https:\/\/doi.org\/10.5152\/eurjrheum.2017.17037","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"5599_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/keg443","volume":"43","author":"JS Ravindran","year":"2004","unstructured":"Ravindran JS, Owen P, Lagan A et al (2004) Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatol (Oxf) 43(1):22\u201326. https:\/\/doi.org\/10.1093\/rheumatology\/keg443","journal-title":"Rheumatol (Oxf)"},{"issue":"1","key":"5599_CR12","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1002\/msc.1694","volume":"20","author":"GE Fragoulis","year":"2022","unstructured":"Fragoulis GE, Siebert S (2022) The role of IL-23 and the use of IL-23 inhibitors in psoriatic arthritis. Musculoskeletal Care 20(1):S12\u2013S21. https:\/\/doi.org\/10.1002\/msc.1694","journal-title":"Musculoskeletal Care"},{"issue":"2","key":"5599_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171\u2013186. https:\/\/doi.org\/10.1097\/PSY.0b013e3181907c1b","journal-title":"Psychosom Med"},{"issue":"8","key":"5599_CR14","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"8","key":"5599_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/ard.2009.122259","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Funovits J et al (2010) Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441\u20131447. https:\/\/doi.org\/10.1136\/ard.2009.122259","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5599_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/acr.24433","volume":"74","author":"E Chew","year":"2022","unstructured":"Chew E, Perin J, Grader-Beck T, Orbai AM (2022) Measurement of minimal disease activity in psoriatic arthritis using the patient-reported outcomes measurement information system-physical function or the health assessment questionnaire disability index. Arthritis Care Res (Hoboken) 74(1):151\u2013160. https:\/\/doi.org\/10.1002\/acr.24433","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"5599_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11136-018-2050-x","volume":"28","author":"M von Glischinski","year":"2019","unstructured":"von Glischinski M, von Brachel R, Hirschfeld G (2019) How depressed is \u201cdepressed\u201d? A systematic review and diagnostic meta-analysis of optimal cut points for the Beck Depression Inventory revised (BDI-II). Qual Life Res 28(5):1111\u20131118. https:\/\/doi.org\/10.1007\/s11136-018-2050-x","journal-title":"Qual Life Res"},{"key":"5599_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","volume":"126","author":"Q Liu","year":"2020","unstructured":"Liu Q, He H, Yang J et al (2020) Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study. J Psychiatr Res 126:134\u2013140. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.08.002","journal-title":"J Psychiatr Res"},{"issue":"6","key":"5599_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11892-014-0491-3","volume":"14","author":"RI Holt","year":"2014","unstructured":"Holt RI, de Groot M, Golden SH (2014) Diabetes and depression. Curr Diab Rep 14(6):491. https:\/\/doi.org\/10.1007\/s11892-014-0491-3","journal-title":"Curr Diab Rep"},{"issue":"2","key":"5599_CR20","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/S2666-7568(22)00291-4","volume":"4","author":"ACE van Gennip","year":"2023","unstructured":"van Gennip ACE, Schram MT, K\u00f6hler S et al (2023) Association of type 2 diabetes according to the number of risk factors within the recommended range with incidence of major depression and clinically relevant depressive symptoms: a prospective analysis. Lancet Healthy Longev 4(2):e63\u2013e71. https:\/\/doi.org\/10.1016\/S2666-7568(22)00291-4","journal-title":"Lancet Healthy Longev"},{"issue":"2","key":"5599_CR21","doi-asserted-by":"publisher","first-page":"101694","DOI":"10.1016\/j.berh.2021.101694","volume":"35","author":"C Stober","year":"2021","unstructured":"Stober C (2021) Pathogenesis of psoriatic arthritis. Best Pract Res Clin Rheumatol 35(2):101694. https:\/\/doi.org\/10.1016\/j.berh.2021.101694","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"5599_CR22","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/art.42617","volume":"75","author":"D Simon","year":"2023","unstructured":"Simon D, Minopoulou I, Kemenes S et al (2023) Baricitinib improves bone properties and biomechanics in patients with rheumatoid arthritis: results of the prospective interventional BARE BONE trial. Arthritis Rheumatol 75(11):1923\u20131934. https:\/\/doi.org\/10.1002\/art.42617","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"5599_CR23","doi-asserted-by":"publisher","first-page":"101689","DOI":"10.1016\/j.berh.2021.101689","volume":"35","author":"H So","year":"2021","unstructured":"So H, Tam LS (2021) Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management. Best Pract Res Clin Rheumatol 35(2):101689. https:\/\/doi.org\/10.1016\/j.berh.2021.101689","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"5599_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","volume":"47","author":"ME Husni","year":"2017","unstructured":"Husni ME, Merola JF, Davin S (2017) The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum 47(3):351\u2013360. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.010","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"5599_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/1756-185X.14298","volume":"25","author":"TL Lai","year":"2022","unstructured":"Lai TL, Au CK, Chung HY et al (2022) Depression in psoriatic arthritis: related to socio-demographics, comorbid loads or disease activity? Int J Rheum Dis 25(4):474\u2013480. https:\/\/doi.org\/10.1111\/1756-185X.14298","journal-title":"Int J Rheum Dis"},{"key":"5599_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/BTT.S260754","volume":"14","author":"MS Chimenti","year":"2020","unstructured":"Chimenti MS, D\u2019Antonio A, Conigliaro P et al (2020) An update for the clinician on biologics for the treatment of psoriatic arthritis. Biologics 14:53\u201375. https:\/\/doi.org\/10.2147\/BTT.S260754","journal-title":"Biologics"},{"issue":"22","key":"5599_CR27","doi-asserted-by":"publisher","first-page":"e3816","DOI":"10.1097\/MD.0000000000003816","volume":"95","author":"CY Wu","year":"2016","unstructured":"Wu CY, Chang YT, Juan CK et al (2016) Depression and insomnia in patients with psoriasis and psoriatic arthritis taking tumor necrosis factor antagonists. Med (Baltim) 95(22):e3816. https:\/\/doi.org\/10.1097\/MD.0000000000003816","journal-title":"Med (Baltim)"},{"issue":"1","key":"5599_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13256-022-03624-z","volume":"16","author":"T Kutsuna","year":"2022","unstructured":"Kutsuna T, Hino K, Hasegawa H et al (2022) Psoriatic arthritis successfully treated with second-line anti-interleukin-6 treatment: a case report and review of the literature. J Med Case Rep 16(1):402. https:\/\/doi.org\/10.1186\/s13256-022-03624-z","journal-title":"J Med Case Rep"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05599-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05599-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:08:14Z","timestamp":1718370494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05599-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["5599"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05599-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the bioethical commission:: Uniwersytet Miko\u0142aja Kopernika w Toruniu, Collegium Medicum im. L. Rydygiera w Bydgoszczy, Komisja Bioetyczna (study number: KB 881\/2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}